Is Propanc Biopharma, Inc. overvalued?

Propanc Biopharma, Inc. (PPCB) — key valuation metrics and fundamentals.

No verdict

Price

$1.22

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$2.8M

Dividend yield

0.0%

Return on equity

-148.2%

Sector

Healthcare

Fair value compares PPCB's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks